Spastic ataxia-corneal dystrophy syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Spastic ataxia-corneal dystrophy syndrome
Synonyms
Pronounce	N/A
Specialty	Neurology, Ophthalmology
Symptoms	Spasticity, ataxia, corneal dystrophy
Complications	N/A
Onset	Childhood
Duration	Lifelong
Types	N/A
Causes	Genetic mutation
Risks	Family history
Diagnosis	Genetic testing, neurological examination, ophthalmological examination
Differential diagnosis	Other forms of ataxia, other corneal dystrophies
Prevention	N/A
Treatment	Physical therapy, occupational therapy, supportive care
Medication	N/A
Prognosis	Variable, depends on severity
Frequency	Rare
Deaths	N/A

A rare genetic disorder affecting the nervous system and eyes

Spastic ataxia-corneal dystrophy syndrome is a rare genetic disorder characterized by a combination of neurological and ocular symptoms. This condition is primarily marked by spasticity, ataxia, and corneal dystrophy.

Presentation

Individuals with spastic ataxia-corneal dystrophy syndrome typically present with a range of symptoms that affect both the nervous system and the eyes.

Neurological Symptoms

The neurological manifestations of this syndrome include:

• Spasticity: Increased muscle tone leading to stiffness and difficulty with movement.
• Ataxia: Lack of voluntary coordination of muscle movements, which can affect gait and balance.
• Hyperreflexia: Exaggerated reflex responses.
• Muscle weakness: Particularly in the lower limbs, contributing to mobility issues.

Ocular Symptoms

The primary ocular symptom associated with this syndrome is:

• Corneal dystrophy: A group of eye disorders in which abnormal material accumulates in the cornea, leading to vision impairment. This can cause symptoms such as blurred vision, eye pain, and sensitivity to light.

Genetics

Spastic ataxia-corneal dystrophy syndrome is believed to be inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The specific genetic mutations responsible for this syndrome have not been fully elucidated, but they are thought to affect proteins involved in nerve and corneal function.

Diagnosis

Diagnosis of spastic ataxia-corneal dystrophy syndrome is based on clinical evaluation, family history, and specialized tests. These may include:

• Neurological examination: To assess muscle tone, reflexes, and coordination.
• Ophthalmologic examination: To evaluate the cornea and detect any dystrophic changes.
• Genetic testing: To identify mutations in genes associated with the syndrome.

Management

There is currently no cure for spastic ataxia-corneal dystrophy syndrome. Management focuses on alleviating symptoms and improving quality of life. Treatment options may include:

• Physical therapy: To improve mobility and reduce spasticity.
• Occupational therapy: To assist with daily activities and enhance independence.
• Medications: Such as muscle relaxants to manage spasticity.
• Regular eye examinations: To monitor and manage corneal changes.

Prognosis

The prognosis for individuals with spastic ataxia-corneal dystrophy syndrome varies depending on the severity of symptoms and the effectiveness of management strategies. Early intervention and supportive care can help improve outcomes and quality of life.

See also

• Ataxia
• Corneal dystrophy
• Spasticity
• Genetic disorder